192 related articles for article (PubMed ID: 2263750)
1. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
[TBL] [Abstract][Full Text] [Related]
2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
[TBL] [Abstract][Full Text] [Related]
3. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin serum concentration and associated amyloidosis in dialysis patients.
Stein G; Schneider A; Thoss K; Ritz E; Schaefer K; Hüller M; Sperschneider H; Marzoll I
Nephrol Dial Transplant; 1991; 6 Suppl 3():57-61. PubMed ID: 1775270
[TBL] [Abstract][Full Text] [Related]
5. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
[TBL] [Abstract][Full Text] [Related]
6. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
[TBL] [Abstract][Full Text] [Related]
7. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
[TBL] [Abstract][Full Text] [Related]
8. Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies.
Zingraff J; Beyne P; Ureña P; Uzan M; Nguyen Khoa Man ; Descamps-Latscha B; Drüeke T
Nephrol Dial Transplant; 1988; 3(3):284-90. PubMed ID: 3140102
[TBL] [Abstract][Full Text] [Related]
9. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
[TBL] [Abstract][Full Text] [Related]
10. Long-term complications of dialysis: pathogenic factors with special reference to amyloidosis.
Gejyo F; Homma N; Arakawa M
Kidney Int Suppl; 1993 Jun; 41():S78-82. PubMed ID: 8320951
[TBL] [Abstract][Full Text] [Related]
11. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
12. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal involvement of dialysis-related amyloidosis.
Takahashi S; Morita T; Koda Y; Murayama H; Hirasawa Y
Clin Nephrol; 1988 Sep; 30(3):168-71. PubMed ID: 3052956
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
Ferreira A; Ureña P; Ang KS; Simon P; Morieux C; Souberbielle JC; de Vernejoul MC; Drüeke TB
Nephrol Dial Transplant; 1995; 10(9):1701-7. PubMed ID: 8559492
[TBL] [Abstract][Full Text] [Related]
15. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
Bommer J; Seelig P; Seelig R; Geerlings W; Bommer G; Ritz E
Nephrol Dial Transplant; 1987; 2(1):22-5. PubMed ID: 3110692
[TBL] [Abstract][Full Text] [Related]
16. Detection of novel beta 2-microglobulin in the serum of hemodialysis patients and its amyloidogenic predisposition.
Ogawa H; Saito A; Oda O; Nakajima M; Chung TG
Clin Nephrol; 1988 Sep; 30(3):158-63. PubMed ID: 3052955
[TBL] [Abstract][Full Text] [Related]
17. Dialysis related amyloidosis: a disease of chronic retention and inflammation?
Floege J; Schäffer J; Koch KM; Shaldon S
Kidney Int Suppl; 1992 Oct; 38():S78-85. PubMed ID: 1405384
[TBL] [Abstract][Full Text] [Related]
18. Behavior of beta 2-microglobulin in patients with chronic renal failure undergoing hemodialysis, hemodiafiltration and continuous ambulatory peritoneal dialysis (CAPD).
Blumberg A; Bürgi W
Clin Nephrol; 1987 May; 27(5):245-9. PubMed ID: 3297439
[TBL] [Abstract][Full Text] [Related]
19. Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies.
Argilés A; Kerr PG; Mourad G; Mion CM; Atkins RC
Nephrol Dial Transplant; 1993; 8(10):1118-23. PubMed ID: 7505905
[TBL] [Abstract][Full Text] [Related]
20. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
Czyz W; Szepietowski T
Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
